KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inovio Pharmaceuticals (INO) Tax Provisions (2018 - 2019)

Inovio Pharmaceuticals' Tax Provisions history spans 3 years, with the latest figure at -$87764.0 for Q4 2019.

  • For Q4 2019, Tax Provisions fell 46535.98% year-over-year to -$87764.0; the TTM value through Sep 2020 reached -$87764.0, up 48.19%, while the annual FY2019 figure was -$257000.0, 111.84% down from the prior year.
  • Tax Provisions for Q4 2019 was -$87764.0 at Inovio Pharmaceuticals, up from -$106771.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $2.2 million in Q1 2018 and bottomed at -$1.8 million in Q3 2015.
  • The 3-year median for Tax Provisions is -$87764.0 (2019), against an average of -$26443.0.
  • The largest YoY upside for Tax Provisions was 102.89% in 2019 against a maximum downside of 46535.98% in 2019.
  • A 3-year view of Tax Provisions shows it stood at -$308520.0 in 2015, then skyrocketed by 100.06% to $189.0 in 2018, then crashed by 46535.98% to -$87764.0 in 2019.
  • Per Business Quant, the three most recent readings for INO's Tax Provisions are -$87764.0 (Q4 2019), -$106771.0 (Q2 2019), and -$62800.0 (Q1 2019).